Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

N-butyl Lithocholic acid is a derivative of the secondary bile acid lithocholic acid (Item No. 20253).1 Lipid nanoparticles (LNPs) containing N-butyl lithocholic acid and encapsulating an mRNA vaccine expressing influenza hemagglutinin exhibit less heart, spleen, and liver toxicity than LNPs containing cholesterol (Item Nos. 9003100 | 39088) in mice.
WARNING This product is not for human or veterinary use.
1. A lipid nanoparticle platform incorporating trehalose glycolipid for exceptional mRNA vaccine safety. Bioact. Mater. 38, 486-498 (2024).